Search results
FII Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Heparin Control, CRYOcheck (frozen)
Abnormal control for activated partial thromboplastin time (aPTT) assays.
Factor XIII Deficient Plasma
For any in vitro protocol or research study where a source of human FXIII deficient plasma is required.
BIOPHEN Normal Control Plasma
Quality control plasma for the corresponding clotting or chromogenic assays, and for non mutated FV (not resistant to APC).
Factor II EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
CEPHEN APTT 5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.